Tech Company Financing Transactions

Akebia Therapeutics Funding Round

On 1/9/2012, Akebia Therapeutics received $4.1 million in Series B financing from AgeChem Venture Fund, Athenian Venture Partners and Kearny Venture Partners.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

245 First St. 1100
Cambridge, MA 02142
USA

Phone

(617) 871-2098

Website

www.akebia.com

Email Address

[email protected]

Overview

Akebia Therapeutics is a biopharmaceutical company and global leader in developing therapies using hypoxia inducible factor (HIF) to treat serious disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Butler

        

Chief Financial Officer

Jason Amello

        

VP - Bus. Development

Karen Tubridy

        

VP - General Counsel

Nikki Hadas

        

VP - Human Resources

Tamara Dillon

        

VP - Operations

Michel Dahan

        

Browse more venture capital transactions:

Prev: 1/9/2012: Avinger venture capital transaction
Next: 1/9/2012: AddThis venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary